Sign up to save your podcasts
Or
Share Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies
Did you know that different types of drug resistance to antibody-drug conjugates (ADCs) can develop at different sites in the same patient? How may this impact ADC sequencing?
Credit available for this activity expires: 12/13/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999152?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape
4.3
2525 ratings
Did you know that different types of drug resistance to antibody-drug conjugates (ADCs) can develop at different sites in the same patient? How may this impact ADC sequencing?
Credit available for this activity expires: 12/13/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999152?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current CME
View all
JAMA Editors' Summary
142 Listeners
AFP: American Family Physician Podcast
700 Listeners
JAMA Clinical Reviews
499 Listeners
JACC This Week
168 Listeners
Diabetes Core Update
102 Listeners
This Week in Cardiology
885 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
292 Listeners
Frankly Speaking About Family Medicine
259 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
Core IM | Internal Medicine Podcast
1,156 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
91 Listeners
The Clinical Problem Solvers
511 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
363 Listeners
Freely Filtered, a NephJC Podcast
172 Listeners
Medicine and the Machine
60 Listeners
Keeping Current
8 Listeners
Cardionerds: A Cardiology Podcast
426 Listeners